Zeria Pharmaceutical Co., Ltd. (4559) Earnings: Operating Income Up 28.3% YoY to 1.95 Billion Yen

Zeria Pharmaceutical Co., Ltd. (4559) reported its latest financial results, showing operating income increased by 28.3% year-on-year to 1,950 million yen. Net sales were 21,448 million yen, a 10.1% increase compared to the same period of the previous year. On the profit front, ordinary income was 1,432 million yen, down 13.8% year-on-year, and net income attributable to owners of the parent decreased by 20.6% to 866 million yen. Earnings per share (EPS) stood at 19.65 yen, with comprehensive income reported at 769 million yen.

From a financial structure and valuation perspective, the company maintains a solid capital adequacy ratio of 61.8%, reflecting a stable financial foundation. Retained earnings stand at 73.1 billion yen against interest-bearing debt of 36.47 billion yen. Regarding profitability indicators, return on equity (ROE) is 1.18% and return on assets (ROA) is 0.50%, highlighting key areas for future performance monitoring.